Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

U.K. MCA would have ad pre-approval authority under proposed rule; broad implementation not likely.

Executive Summary

U.K. PROPOSED AD REG GIVES MCA AUTHORITY TO PRE-APPROVE DRUG ADS, according to a draft issued Aug. 19 and distributed for consultancy Aug. 21. The proposed reg would give the U.K. Medicines Control Agency the latitude to require manufacturers of prescription, pharmacy and general sales drugs to furnish the agency with copies of advertisements that have been published, prepared for publication or proposed for publication, the draft rule explains. MCA could additionally require a manufacturer "to refrain from re-publishing or publishing any advertisement...without the consent of the Health Ministers," during the review period.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS030847

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel